IHM
XLRN

Iguana Healthcare Management’s Acceleron Pharma XLRN Stock Holding History

Iguana Healthcare Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25,000
Closed -$974K – 81
2014
Q4 		$974K Buy
+25,000
New +$871K 0.47% 49

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Iguana Healthcare Management's XLRN Position: Q4 2017 in Review

Iguana Healthcare Management sold out of Acceleron Pharma (XLRN) in Q4 2017, closing a stake of 70,000 shares — an estimated $2.61M sold.

Iguana Healthcare Management first reported a position in XLRN in Q2 2014 and held it in 12 quarters. The position peaked at $8.38M in Q4 2014. 137 funds tracked by Wall St. Rank hold XLRN as of Q4 2017.

  • Iguana Healthcare Management reported no remaining Acceleron Pharma position as of Q4 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 70,000 Acceleron Pharma shares in Q4 2017, an estimated $2.61M.
  • Iguana Healthcare Management first reported a position in Acceleron Pharma in Q2 2014 and held it in 12 quarters.
  • Iguana Healthcare Management's Acceleron Pharma position peaked at $8.38M in Q4 2014.
  • 137 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2017.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.